A protein on a cell structure called the primary cilia links diabetes and obesity. The discovery may lead to new diabetes treatments.
Category: Diseases + conditions
Managing type 1 diabetes: Voices of the underserved
Stanford researchers and others created a project to increase the number of doctors who can provide diabetes care to underserved communities.
Universal hepatitis B screenings can save lives and cut costs, study says
Stanford researchers find that screening all adults in the United States one time for hepatitis B could save money and lives.
Coronavirus takes aim at insulin-producing cells in the pancreas
Stanford Medicine researchers discover that the virus behind COVID-19 attacks insulin-producing cells in the pancreas.
Technology equality gap for kids’ diabetes treatment is growing
As more children and teens with diabetes use technology to treat the disease, U.S. kids of lower socioeconomic status are being increasingly left behind.
Disease detective tells stories of mystery diseases in new book
Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
I wrote a book about a scientist’s journey to save his desperately ill son
Stanford Medicine science writer Tracie White shares the origins of her new book that explores ME/CFS, family bonds, science, suffering, and much more.
Prison ‘aha’ moment leads to research into mental health and addiction
Stanford researcher finds that inpatient psychiatric care helps long-term recovery rates for people with both mental illness and addiction.
Concussion: Could your genes increase your risk?
Stanford scientists have found two genes associated with concussion. Screening football players and military might identify those at higher risk.
Breaking down diabetes: A quick guide to the plethora of medications
As part of the series,Breaking down diabetes, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
Breaking down diabetes: Drugs for diabetes, starting with the best — metformin
Metformin is physician-researcher Randall Stafford's go-to drug for diabetes. He explains why in this installment in the series, Breaking down diabetes.
COVID-19 is taking lives and walloping the economy: What can we learn by looking at both?
Early in the pandemic, COVID-19's blow to the economy was widespread, but deaths were concentrated geographically and by age group.
Easier-to-use technology helps young people with type 1 diabetes
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
Stanford students design a device to detect early-stage river blindness
A team of Stanford undergraduates designed a device that uses blue-light imaging technology to diagnose a parasitic disease called river blindness.
Why air pollution is linked to severe cases of COVID-19
A Stanford researcher discusses how toxic pollutants can make people more susceptible to COVID-19 and why people of color are particularly vulnerable.
High blood pressure drugs don’t increase COVID-19 risk, Stanford study finds
People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.